Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation TCT 2019

Welcome, Introductions, and Session Goals

Presenter: Roxana Mehran

September 28, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

Presentation TCT 2019

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

Presenter: Roxana Mehran

September 28, 2019

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

Presentation TCT 2019

Case #3 Resolution: How Did We Treat This Patient? What Might We Have Done Differently?

Presenter: Roxana Mehran

September 27, 2019

Presentation TCT 2019

Case #3 Introduction: A Case in Which We Might Consider Bridging

Presenter: Roxana Mehran

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

Drop ASA/ REDUCE Duration

Presenter: Roxana Mehran

September 27, 2019

Presentation TCT 2019

Welcome and Introductions

Presenter: Roxana Mehran

September 27, 2019

Presentation TCT 2019

Final Words

Presenter: Roxana Mehran

September 26, 2019

Presentation TCT 2019

Welcome and Introductions

Presenter: Roxana Mehran

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Presenter: Roxana Mehran

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

Video

» Conference Wrap-Up

Saturday Wrap-Up With Dr. C. Michael Gibson, Dr. Roxana Mehran and Dr. Ajay Kirtane

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About #WomenAs1: The Battle for Gender Equality

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

September 27, 2019

Advertisement

Welcome, Introductions, and Session Goals

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Case #3 Resolution: How Did We Treat This Patient? What Might We Have Done Differently?

Case #3 Introduction: A Case in Which We Might Consider Bridging

TCT 2019 Day Two: Transcatheter Valves, New and Old

Drop ASA/ REDUCE Duration

Welcome and Introductions

Final Words

Welcome and Introductions

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Saturday Wrap-Up With Dr. C. Michael Gibson, Dr. Roxana Mehran and Dr. Ajay Kirtane

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About #WomenAs1: The Battle for Gender Equality

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content